1. Home
  2. AMC vs MDXG Comparison

AMC vs MDXG Comparison

Compare AMC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMC
  • MDXG
  • Stock Information
  • Founded
  • AMC 1920
  • MDXG 2006
  • Country
  • AMC United States
  • MDXG United States
  • Employees
  • AMC N/A
  • MDXG N/A
  • Industry
  • AMC Movies/Entertainment
  • MDXG Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMC Consumer Discretionary
  • MDXG Health Care
  • Exchange
  • AMC Nasdaq
  • MDXG Nasdaq
  • Market Cap
  • AMC 1.2B
  • MDXG 1.2B
  • IPO Year
  • AMC 2013
  • MDXG N/A
  • Fundamental
  • Price
  • AMC $2.78
  • MDXG $6.68
  • Analyst Decision
  • AMC Hold
  • MDXG Strong Buy
  • Analyst Count
  • AMC 7
  • MDXG 3
  • Target Price
  • AMC $3.96
  • MDXG $12.00
  • AVG Volume (30 Days)
  • AMC 8.9M
  • MDXG 587.5K
  • Earning Date
  • AMC 05-07-2025
  • MDXG 04-30-2025
  • Dividend Yield
  • AMC N/A
  • MDXG N/A
  • EPS Growth
  • AMC N/A
  • MDXG N/A
  • EPS
  • AMC N/A
  • MDXG 0.28
  • Revenue
  • AMC $4,637,200,000.00
  • MDXG $348,879,000.00
  • Revenue This Year
  • AMC $9.46
  • MDXG $10.04
  • Revenue Next Year
  • AMC $7.01
  • MDXG $11.53
  • P/E Ratio
  • AMC N/A
  • MDXG $23.86
  • Revenue Growth
  • AMC N/A
  • MDXG 8.52
  • 52 Week Low
  • AMC $2.45
  • MDXG $5.47
  • 52 Week High
  • AMC $11.88
  • MDXG $10.14
  • Technical
  • Relative Strength Index (RSI)
  • AMC 42.83
  • MDXG 32.24
  • Support Level
  • AMC $2.85
  • MDXG $6.55
  • Resistance Level
  • AMC $3.00
  • MDXG $7.34
  • Average True Range (ATR)
  • AMC 0.17
  • MDXG 0.36
  • MACD
  • AMC 0.02
  • MDXG -0.04
  • Stochastic Oscillator
  • AMC 60.00
  • MDXG 15.75

About AMC AMC Entertainment Holdings Inc.

AMC Entertainment Holdings Inc is involved in the theatrical exhibition business. It owns, operates, or has interests in theatres located in the United States and Europe. It provides amenities such as plush, power recliners, MacGuffins full bars, AMC Dine-In Theatres, and premium presentation. The company has identified two reportable segments and reporting units for its theatrical exhibition operations, U.S. markets and International markets. It derives key revenue from the U.S.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: